|

Gut Microbiome in Inflammatory Bowel Disease

RECRUITINGSponsored by Kyunghee University Medical Center
Actively Recruiting
SponsorKyunghee University Medical Center
Started2018-04-01
Est. completion2028-03-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03589183

Summary

Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity. In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease

Exclusion Criteria:

* Person with history of using antibiotics or probiotics within previous 2 weeks.

Conditions5

AnxietyCrohn DiseaseDepressionInflammatory Bowel DiseasesUlcerative Colitis

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.